30
CARDIOVASCULAR
hamburger

Why the HeartMate™ 3 LVAD

Time may run out for patients put on the waiting list, to receive a heart transplantation. Their condition may require earlier intervention than a donor heart would become available. Some of these patients may benefit from a left ventricular assist device (LVAD), an implanted heart pump which can help the heart pump oxygen-rich blood throughout the body and potentially improve the symptoms of advanced heart failure.1

An LVAD is designed to restore blood flow and improve survival outcome, functional status, and quality of life in patients while minimizing complications such as stroke and thrombosis. Intended for a broad range of advanced heart failure patients, LVADs are an option for patients with NYHA Class IIIB or IV heart failure and can be used for both short-term and long-term heart support including:

  • Bridge to transplantation: short term (ST) indication (for people waiting for a donor heart)
  • Destination therapy: long term (LT) indication also called permanent support (for people who are ineligible for heart transplantation)

What is a Left Ventricular Assist Device?
Time may run out for patients put on the heart transplantation waiting list. The condition may require earlier intervention than a donor heart would become available. Some patients may benefit from an LVAD.

Advanced Heart Failure Treatment for Better Quality of Life

You may find it reassuring to know that there are thousands of people around the world with LVADs living active, productive lives. They are spending time with friends and family and doing the things they love.2

HeartMate 3 LVADs set the standard in heart failure LVAD therapy through innovation, experience and outstanding outcomes.1 Our goal, like yours, is to keep patients with heart failure moving forward with the best possible quality of life.

This device is commercially available for use in select international markets.

References

  1. Mehra M, Uriel N, Naka Y, et al. A Fully Magnetically Levitated Left Ventricular Assist Device-Final Report. N Engl J Med. 2019;380:1618-1627.
  2. Abbott Data on File as of March 2021

MAT-2107624 v2.0

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.

False
accessibility
© 2021 Abbott. All Rights Reserved. Please read the Legal Notice for further details.

Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to Abbott, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott, except to identify the product or services of the company.

accessibility

DO YOU WISH TO CONTINUE AND EXIT CARDIOVASCULAR.ABBOTT?

CONTENTS OF THE SITE ARE NOT UNDER THE CONTROL OF ABBOTT.